Jafron Biomedical Co. Ltd. Logo

Jafron Biomedical Co. Ltd. (300529)

SZSE

Currency in CNY
14.97
-0.25 (-1.64%)

Closed

Sep 11, 2026

Day's Range

14.90
15.27

52 wk Range

14.73
24.26

Overview - 300529 - Jafron Biomedical Co. Ltd.

Key Statistics

Valuation

Enterprise Value

11.25B

P/E (Trailing)

‪23.91‬

P/E (Forward)

‪9.53‬

PEG Ratio

‪9.53‬

Price / Sales (TTM)

‪6.69‬

Price / Book

‪3.58‬

EV / EBITDA

‪14.19‬

Profitability

Gross Margin

‪79.88%‬

Profit Margin

‪27.49%‬

Operating Margin

‪36.80%‬

Return on Assets

‪8.09%‬

Return on Equity

‪15.98%‬

Ownership

Shares Outstanding

798.60M

Float

374.60M

Held by Insiders

‪50.39%‬

Held by Institutions

‪6.73%‬

Price stats

Beta

‪0.33‬

50-Day Avg

‪16.63‬

200-Day Avg

‪18.57‬

Dividends

Payout Ratio

‪77.61%‬

Frequency

Annual

Analyst Consensus

Buy

2 analysts

Average price target

‪CN¥ 24.11‬

News Teaser - 300529 - Jafron Biomedical Co. Ltd.

News & Analysis

View all news

Market Cap - 300529 - Jafron Biomedical Co. Ltd.

Peers - 300529 - Jafron Biomedical Co. Ltd.

Peer Comparison

Compared with companies in Medical Devices listed on SZSE.

Profile Summary - 300529 - Jafron Biomedical Co. Ltd.

About

Jafron Biomedical Co. Ltd. is a notable entity in the field of biotechnology, primarily focused on the research, development, and production of advanced medical devices, particularly in the area of blood purification. Founded in China, the company specializes in producing blood purifiers used in clinical treatments…

SectorHealthcare
IndustryMedical Devices
Employees2.20K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.